Stem Cell Therapy for Retinitis Pigmentosa In Malaysia

Retinitis Pigmentosa is a set of hereditary eye diseases, with visible symptoms that include the gradual loss of the retina’s light-detecting ability and potential blindness. It usually presents with night blindness primarily, and a slow progressive loss of field of vision with time, it also leads to gradual loss of central vision. It affects the daily functioning of people with this condition.

The potential of Stem Cell Therapy in treating Retinitis Pigmentosa

Stem cell therapy for Retinitis Pigmentosa offered a medical breakthrough in Malaysia that offered hope to patients with Retinitis Pigmentosa through therapeutic procedures. Stem cell treatment is considered a viable option for treating diseases because stem cells are used to restore the damaged tissue of organs, in this case, the retina. They can potentially stop or even in some cases reverse the progression of RP and this means newly found hope for patients who had nearly no stem cell treatment for Retinitis Pigmentosa available. Retinal cells are derived from stem cells, which can mould into any other kind of cells. This procedure, is about replacing the functional cones by implanting these cells into the affected retina in order to salvage the remaining vision. Unlike other diseases where an approach is only focused on the symptoms and or the deficiency, this area of research has the goal of eradicating Retinitis Pigmentosa as it directly seeks to attack the disease itself provoking it.